SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
134 hedge funds and large institutions have $164M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less call options, than puts
Call options by funds: $2.63M | Put options by funds: $4.61M
Holders
134
Holding in Top 10
–
Calls
$2.63M
Puts
$4.61M
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.64M | |
| 3 | +$1.27M | |
| 4 |
BlackRock
New York
|
+$967K |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$486K |
Top Sellers
| 1 | -$5.64M | |
| 2 | -$2.12M | |
| 3 | -$1.2M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$432K |
| 5 |
DMK
David M. Knott
|
-$392K |